National Research (NRC) Set to Post Earnings on Monday

National Research (NASDAQ:NRC) is anticipated to release its Q3 2026 results after the market closes on Monday, October 26th. Analysts expect the company to post earnings of $0.21 per share and revenue of $35.80 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 4:30 PM ET.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.46. The firm had revenue of $35.39 million for the quarter, compared to analyst estimates of $34.90 million. National Research had a return on equity of 164.26% and a net margin of 4.18%. On average, analysts expect National Research to post $0.98 EPS for the current fiscal year and $1.05 EPS for the next fiscal year.

National Research Price Performance

Shares of NASDAQ NRC opened at $21.93 on Friday. The firm has a market capitalization of $498.91 million, a P/E ratio of 87.72 and a beta of 0.25. The company has a debt-to-equity ratio of 13.13, a quick ratio of 0.65 and a current ratio of 0.65. National Research has a one year low of $11.32 and a one year high of $23.68. The company’s fifty day moving average is $21.10 and its two-hundred day moving average is $20.07.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Weiss Ratings cut shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, October 9th. Zacks Research upgraded shares of National Research to a “hold” rating in a research report on Monday, October 5th. Citizens Jmp upped their price target on National Research from $23.00 to $26.00 and gave the company a “market outperform” rating in a report on Wednesday, July 29th. Finally, Wall Street Zen downgraded National Research from a “buy” rating to a “hold” rating in a research report on Saturday, August 15th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, National Research presently has an average rating of “Hold” and an average target price of $26.00.

National Research Company Profile

National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.

Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.